Balance Sheet
Accounts PayablesAccumulated DepreciationAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwillGoodwill & IntangiblesLiabilities and Shareholders EquityNon-Current AssetsNon-Current Deferred Tax LiabilityOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Medicinova (MNOV) Non-Current Deffered Revenue (2021)

Medicinova (MNOV) has disclosed Non-Current Deffered Revenue for 4 consecutive years, with $1.7 million as the latest value for Q2 2021.

  • Quarterly Non-Current Deffered Revenue changed N/A to $1.7 million in Q2 2021 from the year-ago period, while the trailing twelve-month figure was $1.7 million through Jun 2021, changed N/A year-over-year, with the annual reading at $1.7 million for FY2013, 0.01% changed from the prior year.
  • Non-Current Deffered Revenue for Q2 2021 was $1.7 million at Medicinova, roughly flat from $1.7 million in the prior quarter.
  • The five-year high for Non-Current Deffered Revenue was $1.7 million in Q1 2021, with the low at $1.7 million in Q1 2021.